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Abstract
Background Single-photon emission computed tomography
(SPECT) is an important prognostic tool in evaluating coro-
nary artery disease (CAD), with a high negative predictive
value (NPV) for the occurrence of major adverse cardiac
events (MACE). The prognostic value of SPECT is disputed
in women, patients with atrial fibrillation (AF), diabetes, left
bundle branch block (LBBB) and renal impairment.
Methods Seven hundred sixty-two patients without prior his-
tory of CAD who had SPECTwithout perfusion deficits were
followed for 2 years for MACE. Predictive variables for the
occurrence of MACE were reviewed by Cox proportional
hazard regression, considering clinical information, resting-
ECG data and SPECT data.
Results The NPV of SPECT for the occurrence of MACE
within 2 years was 95.8 %. Multivariate Cox regression re-
vealed male gender as the only significant predictor for the
occurrence ofMACE, besides a positive stress ECG at SPECT
and a low LVEF. AF, LBBB, renal impairment and diabetes
had no significant effect on the prognosis after normal
SPECT.
Conclusion SPECT with normal perfusion images has great
NPV in a medium-sized clinic in the Netherlands, even in
patients with LBBB, AF, diabetes and renal impairment.
MACE-free survival, however, was negatively influenced by
male gender; we therefore propose more caution in men.
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Introduction
Ischaemic heart disease is the second cause of death in the
Netherlands, and has a high morbidity and mortality rate [1,
2]. The main cause of myocardial ischaemia is coronary artery
disease (CAD) [3]. Single-photon emission computed tomog-
raphy (SPECT) is an important imaging modality in the anal-
ysis of functional ischaemia in patients with suspected CAD
[3]. SPECT is reported to have great prognostic value for the
occurrence of cardiac events [4–9], with an annual myocardial
infarction (MI) rate after negative SPECT of 0.8 % [7]. An
important limitation in the use of SPECT is the reduced
sensitivity of balanced ischaemia in three-vessel CAD [10].
There have been doubts about the prognostic value of
SPECT in certain subgroups. Studies have shown that women
[7], patients with renal impairment (eGFR<60) [11–13] and
patients with atrial fibrillation (AF) [14, 15] have a higher
event rate after normal SPECT. Furthermore, the prognostic
use of SPECT in diabetic patients and patients with left bundle
branch block (LBBB) has also been disputed.
Recent studies have shown similar event rates after normal
SPECT in diabetics compared with non-diabetics [16], al-
though balanced triple-vessel disease is more common in
diabetics [17] and thus may cause underestimation of func-
tional ischaemia on SPECT.
Patients with LBBB have intrinsically abnormal con-
duction and are reported to have a related pattern of
perfusion abnormalities. A recent study, however, has
shown that prognosis of a normal SPECT was not
altered by LBBB [18].
The questions can be answered after the article has been published in
print. You have to log in to: www.cvoi.nl.
M. J. Bom (*) :R. Uijlings : E. A. Badings : F. M. A. C. Martens
Department of Cardiology, Deventer Hospital, N. Bolkesteinlaan 75,
7416 SE Deventer, the Netherlands
e-mail: bommichiel@gmail.com
J. M. B. Manders
Department of Nuclear Medicine, Deventer Hospital, N.
Bolkesteinlaan 75, 7416 SE Deventer, the Netherlands
Neth Heart J (2014) 22:151–157
DOI 10.1007/s12471-014-0524-1
Population definition and pre-test likelihood are of great
influence on reported prognosis and thus it is crucial to have
representable data about our specific population.
Aim
The aim of this study was therefore to evaluate the negative
predictive value (NPV) of combined exercise and pharmaco-
logical stress SPECT with attenuation correction (AC) in
patients without a prior history of CAD in a Dutch hospital,




We identified 1491 patients who underwent SPECT be-
tween 28 April 2009 and 28 February 2011 in Deventer
Hospital. Patients with a prior history of CAD were
excluded, as defined by previous MI, revascularisation
and/or significant stenosis on coronary angiography, as
documented in the medical records. Furthermore, patients
with ischaemia and with signs of prior infarction on
SPECT were excluded. The remaining total number of
studied patients was 762 (Fig. 1).
Data acquisition
Data were collected from the Electronic Medical Record
(EMR) by reviewing letters and reports of the treating
cardiologist and other clinicians, reports and letters of
clinicians in other hospitals, laboratory results, reports of
SPECT by the nuclear medicine physician and the im-
ages of SPECT.
Patient preparation and stress protocol
Patient preparation was done according to the American So-
ciety of Nuclear Cardiology protocol [19].
Adenosine (0.14 mg/kg/min) was infused intravenously for
6 min, and Tc-99m Tetrofosmine was injected after at least
3 min. Adenosine stress was combined with low level tread-
mill exercise, 20–70 W maximum. Contraindications for ex-
ercise were LBBB, paced rhythm and inability to exercise.
Dobutamine stress was performed in patients with severe
chronic obstructive pulmonary disease. Dobutamine was ad-
ministered intravenously, starting at a dose of 10 μg/kg/min.
The dose was increased 10 μg/kg/min every 3 min until a
heart rate of 85 % of the age-predicted maximum heart rate
(220-age) was reached, with a maximum of 40 μg/kg/min. A
maximum of two additional intravenous injections of atropine
0.5 mg were given.
SPECT acquisition protocol
Data acquisition was performed using a dual head General
Electric Infinia Hawkeye gamma camera (2006) with low
energy high resolution collimators. Sixty projections over an
angle of 180° were acquired. Acquisition times for rest and
stress were 20 s and 18 s, respectively, per projection. The
energy acceptance window was set at 15–20 %, 140 keV
centre. An additional eight frame gated dataset was acquired
with an acceptance window of 100 %. CT-based ACwas used
with 140 kV tube voltage and 2.5 mAs tube current. Quanti-
tative gated SPECT software (Cedars-Sinai) was used to au-
tomatically calculate end-diastolic volume, end-systolic vol-
ume and left ventricular ejection fraction (LVEF). All non-AC
images were reconstructed by filtered backward projection,
using a 2D Butterworth filter with an order of 8, 0.3 cycles/
pixel. AC and non-AC images were reconstructed by OSEM
iterative reconstruction with 2 iterations and 10 subsets.
Patients underwent a 1-day rest-stress acquisition protocol.
Rest acquisition was performed 15–30 min after intravenous
injection of 250 MBq Tc-99m-tetrofosmine, stress acquisition
was performed 15–30 min after intravenous injection of
750 MBq Tc-99m-tetrofosmine. A 2-day protocol was per-
formed in 11 patients because of inadequate patient prepara-
tion and in 1 patient because of the low quality of initial stress
images.Fig. 1 Inclusion flowchart
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Image interpretation
The visual interpretation of perfusion images was based on
short-axis and vertical and horizontal long-axis tomograms
divided into 20 segments using Myometrix (GE) software.
The nuclear medicine physician reviewed all segments, in
both AC and non-AC images, to review the presence of
ischaemia.
Follow-up
The follow-up time was 2 years from the time of inclu-
sion. Patients were followed for major adverse cardiac
events (MACE) and all-cause mortality. MACE was de-
fined as fatal and non-fatal MI and revascularisation,
consisting of percutaneous coronary intervention (PCI)
and coronary artery bypass graft (CABG). MI was defined
by typical symptoms and raised troponin-T levels. In 1
case troponin-T was not documented and MI was defined
by reviewing the cardiologist letter and the CABG oper-
ation report from a tertiary clinic.
Statistical analysis
Statistical analysis was performed with SPSS software (ver-
sion 20.0.0, IBM). A p-value <0.05 was considered statisti-
cally significant.
To evaluate the prognosis of patients over time in the
different subgroups, univariate and subsequent multivar-
iate Cox proportional hazard regression were performed.
Variables included in the univariate analysis consisted of
clinical data, resting-ECG data and SPECT data. Selec-
tion of variables for entry in the multivariable Cox
proportional hazard regression was based on univariate
analysis (with a threshold of p<0.15) and clinical judg-
ment. The multivariate Cox regression was done step-
wise according to the backwards approach, with p<0.10
as threshold for removal of variables.
The rule of thumb in multivariate Cox regression
models is that the events per variable (EPV) must be at
least 10 to produce a reliable model [20, 21]. However, a
recent study demonstrates that an EPV of 5–10 gives
similar reliability to an EPV ≥10 [22]. Therefore in our
study with 32 events, a prediction model may contain 3–6
variables.
The assumption of proportional hazard was tested by
obtaining and reviewing the log-minus-log plots, and deemed
appropriate in all categories.
To test the linearity assumption of the continuous variable
age, martingale residuals were generated from the Cox regres-




The mean age in the 762 included patients was 63.2 years. Of
the patients 58.1 % were female and 116 (15.2 %) presented
with typical chest pain. The average number of risk factors
was 2.0. A total overview of clinical data, ECG data and
SPECT data is shown in Table 1.
Outcome
Of the 762 studied patients, 32 (4.2 %) had MACE
within follow-up: 1 patient (0.1 %) died of MI, 8
(1.0 %) patients had non-fatal MI, in 12 (1.6 %) pa-
tients CABG was performed and 21 (2.8 %) received
PCI. The all-cause mortality in our study population
was 15 (2.0 %). The NPV of SPECT for the occurrence
of MACE within 2 years was 95.8 % and the NPV for
MI only was 98.8 %. An overview of MI, MACE and
the NPV of SPECT in the various subgroups is given in
Table 2.
Prediction model for the occurrence of MACE
Univariate and subsequent stepwise multivariate Cox
proportional hazard regression was performed and the
results are presented in Table 3. The variables with a p-
value <0.15 on univariate analysis and the clinically
important variables AF, DM, renal impairment and
LBBB were included in the multivariate Cox regression.
The only significant independent predictors of MACE
were male gender, positive stress ECG on SPECT and
low LVEF. AF and hypertension tended to be indepen-
dent predictors, but were not significant.
Discussion
Outcome
Our results show that the prognosis of combined stress
SPECT with AC without perfusion deficits is very good in
patients without a prior history of CAD, with an NPV for the
occurrence of MACE within 2 years of 95.8 % and an NPV
for MI of 98.8 %.
Statistical analysis showed that besides positive stress
ECG at SPECT and low LVEF, male gender was the
only significant independent predictor for the occurrence
of MACE. Thus, the prognosis of a negative SPECT
result is not altered by AF, diabetes, LBBB and renal
impairment.
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Overall population
The prognosis after normal SPECT in patients without prior
history of CAD has not been previously researched in terms of
MACE-free survival. Our study therefore provides key infor-
mation for the use of SPECT in a medium-sized clinic in the
Netherlands. Only two studies are published evaluating the
prognosis of a normal SPECT in patients without prior history
of CAD in terms ofMI rate. These studies report an annualMI
rate of 0.6 % following a normal SPECT result [6, 23], which
is in accordancewith theMI rate of 1.2%within 2 years found
in our study.
Subgroups
The greater prognostic value of SPECT in women compared
with men, as seen in our study, has not previously been
reported. Prior studies even show that women have a slightly
higher event rate than men after normal SPECT [7]. These
studies are predominantly performed in large clinics outside




Women 443 (58.1 %)
Clinical symptoms
- Typical chest pain 116 (15.2 %)
- Atypical chest pain 444 (58.3 %)
- No chest pain 202 (26.5 %)
Risk factors
- Diabetes 155 (20.3 %)
- Hypertension 389 (51.0 %)
- Family history (n=750)a 315 (42.0 %)
- Smoking (present and former) 342 (44.9 %)
- High cholesterol 324 (42.5 %)
Total risk factors (n=750)a 2.0±1.2
Renal function (n=739)e
- eGFR ≥60 664 (89.9 %)
- eGFR 30–60 58 (7.6 %)
- eGFR <30 17 (2.2 %)
Cardiac history
- Atrial fibrillation 83 (10.9 %)
- Other SVT 21 (2.8 %)
- Valvular disease 40 (5.2 %)
- Cardiomyopathy 17 (2.2 %)
- Heart failure, systolic 17 (2.2 %)
- Pacemaker placement 10 (1.3 %)
- Valve operation 8 (1.0 %)
- Heart failure, diastolic 7 (0.9 %)
- High grade AV block 3 (0.4 %)
- Ventricular tachycardia 2 (0.3 %)
- ICD 1 (0.1 %)
Resting ECG
- Signs of prior MI 18 (2.4 %)
- Signs of ischaemia 122 (16.0 %)
- Atrial fibrillation 67 (8.8 %)
- Left bundle branch block 19 (2.5 %)
SPECT data
Type of stress
- Adenosine + exercise 611 (80.2 %)
- Adenosine only 125 (16.4 %)
- Dobutamine only 14 (1.8 %)
- Dobutamine + atropine 10 (1.3 %)
- Exercise + atropine 2 (0.3 %)
SPECT with AC 753 (98.8 %)
Positive exercise ECG at SPECT (n=760)c 150 (19.7 %)
Triple vessel disease not excludede 39 (5.1 %)
Summed difference score (SDS) >2 127 (16.5 %)
Functional data
- LVEF <45 (n=758)d 41 (5.4 %)
- EDV >120 113 (14.8 %)
Table 1 (continued)
n=762 Number (%)
- ESV >60 89 (11.7 %)
eGFR estimated glomerular filtration rate, Other SVTAV nodal re-entry
tachycardia/atrial flutter, ICD implantable cardioverter defibrillator, AC
attenuation correction, LVEF left ventricular ejection fraction, EDV end-
diastolic volume, ESV end-systolic volume, Triple vessel disease not
excluded due to ventricular wall motion abnormalities or abnormal func-
tional data
a In 12 cases family history was not obtained
b eGFR was not obtained in 23 patients
c In two patients stress ECG was not obtained due to technical difficulties
d In four cases LVEF was unreliable, due to AF or GI activity
e Triple vessel disease could not be excluded due to wall motion
abnormalities
Table 2 Outcome and negative predictive value
MI (%) MACE (%) NPV for MACE
Overall 9 (1.2 %) 32 (4.2 %) 95.8 %
Women 1 (0.2 %) 8 (1.8 %) 98.2 %
AF 2 (1.9 %) 2 (1.8 %) 98.2 %
DM 2 (1.3 %) 9 (5.8 %) 94.2 %
LBBB 1 (1.9 %) 4 (7.7 %) 92.3 %
Renal impairment 2 (2.7 %) 4 (5.3 %) 94.7 %
Severe renal impairment 1 (5.9 %) 2 (11.8 %) 88.2 %
AF atrial fibrillation (prior history/on ECG at presentation), DM diabetes
mellitus, LBBB left bundle branch block, renal impairment eGFR<60,
severe renal impairment eGFR<30
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the Netherlands. Our results may be more representative for
clinics in the Netherlands. Research in the Leiden University
Medical Centre showed a worse prognosis of MACE in 5.9 %
of patients [24]. This study, however, was performed in a
higher risk population and with a broader definition of
MACE. The worse prognosis in men is an important finding
for the daily practice in our hospital and in comparable clinics.
Clinicians should be more careful in interpreting normal
SPECT in men.
Unlike our results, prior studies show a higher event rate in
AF patients after normal SPECT than in non-AF patients [15].
These studies defined AF only by findings on the baseline
resting ECG. Both paroxysmal and persistent AF are known
to have increased risk of developing MACE [25, 26].
Therefore, we also included patients with a prior history of
AF to analyse the NPVof SPECT in AF patients. Our study is
the first to show that the prognosis of normal SPECT in AF
patients (on baseline resting ECG and prior history) is com-
parable with that of non-AF patients.
Patients with renal impairment (eGFR<60) are reported to
have a worse prognosis after normal SPECT than patients
with normal renal function [11–13]. Our study, however, did
not show any difference inMACE-free survival between these
patients. Although patients with severe renal impairment
(eGFR<30) seemed to have a worse prognosis, with MACE
in 11.8% of patients, no statistically significant difference was
proven.
The similar prognosis of diabetics and non-diabetics after
normal SPECT is in accordance with prior studies [16]. How-
ever, the event rate after normal SPECT, although initially
similar, is reported to increase after 2 years of follow-up and
thus a shorter warranty period of SPECT may apply in dia-
betic patients [16]. One must be cautious about using our data
to predict the long-term prognosis of a normal SPECT in
diabetic patients.
Patients with LBBB are known to have an abnormal con-
duction pattern, associated with abnormal perfusion images.
When this is taken into account, patients with LBBB are
reported to have a similar prognosis after normal SPECT to
patients without LBBB [18]. Although the prognosis seemed
worse, with MACE in 7.7 % of LBBB patients, compared
with 2.6 % in non-LBBB patients, no difference in MACE-
free survival was found. However, the small cohort of 52
LBBB patients limits the extrapolation of results and therefore
we advise clinicians to be cautious when reviewing normal
SPECT in LBBB patients.
Limitations
Recently, software has been developed to automatically
quantify perfusion in SPECT. The automated quantitative
scores are reported to have greater prognostic value [27]
and reproducibility than visual assessment [28]. In our
study, perfusion images of SPECT were visually assessed,
because local experience with the visual approach was
greater than with automated quantitative software. Al-
though SPECT is known to have little intra- and inter-
observer variability in experienced observers [3, 29, 30],
the reliance upon the expertise of the observer limits the
extrapolation of our results to other centres.
The definition of MI was also subject to inter-observer
variability, because the cardiologist’s interpretation and
clinical judgement played an important role in deter-
mining whether the patient presented with classical signs
of MI.
Our population of 762 patients was sufficient to investigate
the NPV of a negative SPECT in the overall population,
Table 3 Univariate and subsequent multivariate Cox regression of clin-
ical data, ECG findings and SPECT data on MACE
Variable HR 95 % CI P-value
Univariate analysis
Male gender 4.266 1.916–9.496 <0.001*
Age 1.021 0.990–1.052 0.189
Typical chest pain 1.885 0.847–4.196 0.120*
DM 1.523 0.705–3.292 0.285
Hypertension 1.856 0.895–3.850 0.097*
Family history 1.222 0.610–2.447 0.572
Smoking 1.088 0.544–2.179 0.811
High cholesterol 1.189 0.594–2.380 0.625
Renal impairment 1.272 0.446–3.625 0.653
Severe renal impairment 2.917 0.697–12.207 0.143*
AF 0.403 0.096–1.687 0.213
ECG: prior MI 1.330 0.182–9.744 0.779
ECG: ischaemia 0.535 0.163–1.755 0.302
ECG: LBBB 2.021 0.709–5.761 0.188
Adenosine only 0.799 0.327–1.955 0.623
Stress ECG at SPECT 2.257 1.082–4.711 0.030*
LVEF < 45 % 4.369 1.798–10.615 0.001*
ESV > 60 2.165 0.937–5.006 0.071*
EDV > 120 3.110 1.500–6.451 0.002*
Triple vessel disease not excluded 3.638 1.401–9.448 0.008*
Multivariate analysis
Male gender 4.710 2.054–10.801 <0.001
Hypertension 1.960 0.936–4.105 0.074
Stress ECG at SPECT 3.079 1.460–6.495 0.003
LVEF < 45 % 3.967 1.584–9.934 0.003
AF 0.303 0.071–1.294 0.107
LVEF left ventricular ejection fraction, EDV end-diastolic volume, ESV
end-systolic volume, DM diabetes mellitus, AF atrial fibrillation (prior
history/on ECG at presentation), MI myocardial infarction, LBBB left
bundle branch block, Renal impairment eGFR<60, severe renal
impairment eGFR<30
*: variables with p<0.15 on univariate analysis
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despite the limited number of events. However, the number of
patients in the various subgroups was often small. To prove
statistically significant differences in MACE-free survival in
subgroups larger study populations are needed, especially in
patients with LBBB and patients with severe renal impair-
ment. The limited number of events also compromised the
reliability of the prediction model generated by the Cox pro-
portional hazard regression.
Conclusion
Our study shows that the negative predictive value of com-
bined stress SPECT with AC on the occurrence of MACE
within 2 years in patients without prior CAD in a medium-
sized clinic in the Netherlands is very good, even in patients
with AF, diabetes and moderate renal impairment. However,
caution is advised when reviewing SPECT in men, patients
with LBBB and patients with severe renal impairment. Statis-
tical analysis showed significantly worseMACE-free survival
in men. MACE-free survival also seemed worse in patients
with LBBB and patients with severe renal impairment, but this
was not significant. Further prospective research is needed in
these patients.
Funding This work was not supported with any grants and did not
receive funding of any kind.
Conflict of interest None declared.
Open Access This article is distributed under the terms of the Creative
Commons Attribution License which permits any use, distribution, and
reproduction in any medium, provided the original author(s) and the
source are credited.
References
1. Centraal Bureau voor de Statistiek. Doodsoorzaken; maand en jaar
van overlijden. 2013. Available at: http://statline.cbs.nl/StatWeb/
publication/?VW=T&DM=SLNL&PA=71594ned&LA=NL.
Accessed 15–01, 2013.
2. Murray CJ, Lopez AD. Evidence based health policy—lessons from
the Global Burden of Disease Study. Science. 1996;274:740–3.
3. Fox K, Alonso Garcia MA, Ardissino D, et al. Guidelines on the
management of stable angina pectoris: executive summary. The Task
Force on the Management of Stable Angina Pectoris of the European
Society of Cardiology. Eur Heart J. 2006;27:1341–81.
4. Mowatt G, Brazzelli M, Gemmellb H, et al. Systematic review of the
prognostic effectiveness of SPECT myocardial perfusion scintigra-
phy in patients with suspected or known coronary artery disease and
following myocardial infarction. Nucl Med Commun. 2005;26:217–
29.
5. Schinkel AFL, Elhendy A, Van Domburg RT, et al. Incremental value
of exercise technetium-99m tetrofosminmyocardial perfusion single-
photon emission computed tomography for the prediction of cardiac
events. Am J Cardiol. 2003;91:408–11.
6. Shaw LJ, Hendel R, Borges-Neto S, et al. Prognostic value of normal
exercise and adenosine 99mTc-tetrofosmin SPECT imaging: results
from the multicenter registry of 4,728 patients. Nucl Med. 2003;44:
134–9.
7. Shaw LJ, Iskandrian AE. Prognostic value of gated myocardial
perfusion SPECT. J Nucl Cardiol. 2004;11:171–85.
8. Jain D, Lessig H, Patel R, et al. Influence of 99mTc-tetrofosmin
SPECT myocardial perfusion imaging on the prediction of future
adverse cardiac events. J Nucl Cardiol. 2009;16:540–8.
9. Boiten HJ, van der SijdeNJ, Ruitinga PR, et al. Long-term prognostic
value of exercise technetium-99m tetrofosmin myocardial perfusion
single-photon emission computed tomography. J Nucl Cardiol.
2012;19:907–13.
10. Beller GA. Underestimation of coronary artery disease with SPECT
perfusion imaging. J Nucl Cardiol. 2008;15:151–3.
11. Hakeem A, Bhatti S, Dillie KS, et al. Predictive value of myocardial
perfusion single-photon emission computed tomography and the
impact of renal function on cardiac death. Circulation. 2008;118:
2540–9.
12. Al-Mallah MH, Hachamovitch R, Dorbala S, et al. Incremental
prognostic value of myocardial perfusion imaging in patients referred
to stress single-photon emission computed tomography with renal
dysfunction. Circ Cardiovasc Imaging. 2009;2:429–36.
13. Okuyama C, Nakajimab K, Hattac T, et al. Incremental prognostic
value of myocardial perfusion single photon emission computed
tomography for patients with diabetes and chronic kidney disease.
Nucl Med Commun. 2011;32:913–9.
14. Askew JW, Miller TD, Hodge DO, et al. The value of myocardial
perfusion single-photon emission computed tomography in screening
asymptomatic patients with atrial fibrillation for coronary artery
disease. J Am Coll Cardiol. 2007;50:1080–5.
15. Abidov A, Hachamovitch R, Rozanski A, et al. Prognostic implica-
tions of atrial fibrillation in patients undergoing myocardial perfusion
single-photon emission computed tomography. J Am Coll Cardiol.
2004;44:1062–70.
16. Giri S, Shaw LJ, Murthy D, et al. Impact of diabetes on the risk
stratification using stress single-photon emission computed tomogra-
phy myocardial perfusion imaging in patients with symptoms sug-
gestive of coronary artery disease. Circulation. 2002;105:32–40.
17. Fallow GD, Singh J. The prevalence, type and severity of cardiovas-
cular disease in diabetic and non-diabetic patients: a matched-paired
retrospective analysis using coronary angiography as the diagnostic
tool. Mol Cell Biochem. 2004;261:263–9.
18. Ten Cate TJF, Kelder JC, Plokker HWM, et al. Myocardial perfusion
SPECT identifies patients with left bundle branch block patterns at
high risk for future coronary events. J Nucl Cardiol. 2010;17:216–24.
19. Henzlova MJ, Cerqueira MD, Mahmarian JJ, et al. Stress protocols
and tracers. J Nucl Cardiol. 2006;13:e80–90.
20. Peduzzi P, Concato J, Kemper E, et al. A simulation study of the
number of events per variable in logistic regression analysis. J Clin
Epidemiol. 1996;49:1373–9.
21. Concato J, Peduzzi P, Holfold TR, et al. Importance of events per
independent variable in proportional hazards analysis. I. Background,
goals, and general strategy. J Clin Epidemiol. 1995;48:1495–501.
22. Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per
variable in logistic and Cox regression. Am J Epidemiol. 2007;165:
710–8.
23. Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk
and its temporal variation in patients with normal stress myocardial
perfusion scans: what is the warranty period of a normal scan? J Am
Coll Cardiol. 2003;41:1329–40.
24. America YG, Bax JJ, Boersma E, et al. The additive prognostic value
of perfusion and functional data assessed by quantitative gated
SPECT in women. J Nucl Cardiol. 2009;16:10–9.
156 Neth Heart J (2014) 22:151–157
25. Weijs B, de Vos CB, Tieleman RG, et al. The occurrence of cardio-
vascular disease during 5-year follow-up in patients with idiopathic
atrial fibrillation. Europace. 2013;15:18–23.
26. Osranek M, Bursi F, Bailey KR, et al. Left atrial volume
predicts cardiovascular events in patients originally diagnosed
with lone atrial fibrillation: three-decade follow-up. Eur Heart
J. 2005;26:2556–61.
27. Leslie WD, Tully SA, Yogendran MS, et al. Prognostic value of
automated quantification of 99mTc-sestamibi myocardial perfusion
imaging. J Nucl Med. 2005;46:204–11.
28. Xu Y, Hayes S, Ali I, et al. Automatic and visual reproducibility of
perfusion and function measures for myocardial perfusion SPECT. J
Nucl Cardiol. 2010;17:1050–7.
29. Garcia EV. SPECT attenuation correction: an essential tool to realize
nuclear cardiology’s manifest destiny. J Nucl Cardiol. 2007;14:16–
24.
30. Golub RJ, Ahlberg AW, McClellan JR, et al. Should SPET
attenuation correction be more widely employed in routine
clinical practice? For Eur J Nucl Med Mol Imaging. 2002;29:
409–12.
CVOI E-learning formula!
This is the CVOI e-learning article. The author has prepared 10 questions which are
available through the website of the Cardiovascular Educational Institute (CVOI).
Please follow the instructions below.
After finishing the questions you will be asked to fill in your name, hospital and e-mail address; then press the button
'verzenden'.
When 6 out of the 10 questions are answered correctly, you acquire 1 accreditation point granted by the Quality Committee
of the Netherlands Society of Cardiology (NVVC). The acquired point will be credited to your personal file in the GAIA
system. You will also receive an e-mail with all the correct answers.
Over a period of one year 10 e-learning articles will appear in 10 subsequent NHJ editions. In each edition the e-learning
article will be recognisable by a special icon. On an annual basis you can collect 10 accreditation points. The accreditation
points are credited in the GAIA system by the CVOI.
If you need additional information, please contact the CVOI by e-mail: cvoi@cvoi.org or by phone: 030-2345001.
kcihcS.B.KllaWrednav.E.E
IOVCrotanidrooCJHNrotidefeihC
Neth Heart J (2014) 22:151–157 157
